89bio, Inc.
ETNBDelisted Oct 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785173
89bio, Inc. was delisted on Oct 30, 2025; its insiders filed their last Form 4 on Nov 3, 2025; 198 institutions reported holding it in 13F filings for Q3 2025, worth $2.27B in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding 89bio, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 70 | 86 | +16 |
| Shares | 32.5M | 39.3M | +6.80M (+20.9%) |
| Value | $104.6M | $227.3M | +$122.8M (+117.4%) |
New holders (30)
Institutions that held 89bio, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (14)
Institutions that held 89bio, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| TCG Crossover Management, LLC | 1,133,196 | $3.65M |
| Deerfield Management Company, L.P. (Series C) | 506,100 | $1.63M |
| Alyeska Investment Group, L.P. | 300,000 | $966.0K |
| Pentwater Capital Management LP | 220,000 | $708.0K |
| D. E. Shaw & Co., Inc. | 94,036 | $303.0K |
| Hudson Bay Capital Management LP | 77,126 | $248.0K |
| Susquehanna International Group, LLP | 55,519 | $179.0K |
| Ergoteles LLC | 47,600 | $153.0K |
| Simplex Trading, LLC | 20,057 | $64.0K |
| PDT Partners, LLC | 10,274 | $33.0K |
| Squarepoint Ops LLC | 10,348 | $33.0K |
| Federated Hermes, Inc. | 981 | $3.00K |
| New York State Common Retirement Fund | 86 | $0 |
| Credit Suisse AG | 5 | $0 |